Company: BDRX
Filing Date: 2025-06-13
Form Type: 424B3
Source: 0001214659-25-009218
Chunk: 36

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-06-13
Form: 424B3
Chunk 36
---
 directors                                 
 may from time to time permit appointments of a proxy to be made by means of an electronic communication in the form of an Uncertificated       
 Proxy Instruction, (that is, a properly authenticated dematerialised instruction, and/or other instruction or notification, which is sent      
 by means of the relevant system concerned and received by such participant in that system acting on behalf of the company as the directors     
 may prescribe, in such form and subject to such terms and conditions as may from time to time be prescribed by the directors (subject          
 always to the facilities and requirements of the relevant system concerned)); and may in a similar manner permit supplements to, or amendments 
 or revocations of, any such Uncertificated Proxy Instruction to be made by like means. The directors may in addition prescribe the method      
 of determining the time at which any such properly authenticated dematerialised instruction (and/or other instruction or notification)         
 is to be treated as received by the company or such participant. The directors may treat any such Uncertificated Proxy Instruction which       
 purports to be or is expressed to be sent on behalf of a holder of a share as sufficient evidence of the authority of the person sending       
 that instruction to send it on behalf of that holder.                                                                                          |

| 29 |

| 58.3 | The appointment of a proxy and any authority under which it is executed or a copy of the authority certified 
 notarially or in some other way approved by the Board may:                                                   |

| (A) | in the case of an instrument in writing be deposited at the Registered Office or at such other place in                                   
 the United Kingdom as is specified in the notice convening the meeting, or in any instrument of proxy sent out by the Company in relation 
 to the meeting, not less than 48 hours before (excluding any day that is not a working day) the time for holding the meeting or adjourned 
 meeting at which the person named in the instrument proposes to vote; or                                                                  |

| (B) | in the case of an appointment contained in an electronic communication, be received at the address specified 
 for the purpose of receiving electronic communications:                                                      |

| (1) | in any instrument of proxy sent out by the Company in relation to the meeting; or |

| (2) | in any invitation contained in an electronic communication to appoint a proxy issued by the Company in 
 relation to the meeting; or                                                                            |

| (3) | as has been made available, throughout the period beginning with